vTv Therapeutics Inc. (VTVT)
NASDAQ·Healthcare·Biotechnology
$30.71
-1.25%
Mkt Cap $95.58M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$42.00
Range $42.00 – $42.00
Implied Upside
+36.8%
Consensus $42.00 vs current $30.71
NASDAQ·Healthcare·Biotechnology
$30.71
-1.25%
Mkt Cap $95.58M
No recent rating data.
Price Target (4 analysts)
$42.00
Range $42.00 – $42.00
+36.8%
Consensus $42.00 vs current $30.71